CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma
Clinical trial NCT05289193 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05289193
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-11
- Primary completion
- 2027-03-11
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.